This page contains recent publications only.

  1. Zhixing S, Wang R, Wu C, Murcy M, Gillis A, Fazendin J, Lindeman B, Chen H. Traveling to Find A Surgeon: An International Patient-Driven Registry. Journal of Surgical Research, 2023 November. Manuscript Number: JSURGRES-D-23-01956.
  2. Hood C, Zmijewski P, McLeod C, Herring B, Bahl D, Fazendin J, Lindeman B, Chen H, Gillis A. Young & Resilient: Unraveling Papillary Thyroid Cancer Outcomes in Males Under 40. World Journal of Surgery, 2024, February. Manuscript Number: WJSU-2023-0073.R2.
  3. Fisher Y, Fazendin J, Chen H, Lindeman B, Gillis A. Evaluating Patient’s Health Literacy to Improve Thyroid Pathology Reports. Journal of Surgical Research. The Journal of Surgical Research. March 12, 2023. Manuscript number: JSURGRES-D-23-01179R1.
  4. Tomblin C, Wang R, McMullin J, Chen H, Gillis A. The Rich Get Richer: The Matthew Effect in Open Payments. Journal of Surgical Research, 2023 Oct 13:293:693-700. doi: 10.1016/j.jss.2023.08.052.
  5. McElroy K, Fazendin J, Chen H, Lindeman B, Gillis A. Funding a General Surgery Residency Academic Development Program. The American Journal of Surgery, 2023 Oct 4:S0002-9610(23)00510-X. doi: 10.1016/j.amjsurg.2023.10.002.
  6. Wang R, Liu McMullin J, Allahwasaya A, Akhund R, Fazendin J, Lindeman B, Chen H. Gillis A. Feasibility of An Online Patient-driven international Parathyroid Registry. J Surg Res. 2024 Jan 28:296:217-222. doi: 10.1016/j.jss.2024.01.004
  7. Nakanishi H, Wang R, Miangul S, Kim G, Segun-Omosehin A, Bourdakos N, Than C, Johnson B, Chen H, Gillis A. Clinical Outcomes of Outpatient Thyroidectomy: A Systematic Review and Single-Arm Meta-Analysis. . Am J Surg. 2024. Epub 20240227. doi: 10.1016/j.amjsurg.2024.02.037. PubMed PMID: 38443270.
  8. Wu C, Abraham P, Wang R, Herring B, Zmijewski P, Gillis A, Fazendin J, Lindeman B, Chen H. The overtreatment of papillary thyroid microcarcinoma in the community. Am J Surg. 2024. Epub 20240304. doi: 10.1016/j.amjsurg.2024.03.004. PubMed PMID: 38462410.
  9. Gillis A, Zmijewski P, McLeod MC, Lindeman B, Fazendin J, Chen H, Bhatia S. Racial Implications of Time to Surgery in Disparities in Thyroid Cancer Survival. The American Journal of Surgery. 2024. doi: 10.1016/j.amjsurg.2024.02.002.
  10. Song Z, Wu C, Wang R, Gillis A, Fazendin J, Lindeman B, Chen H. The effects of Parathyroidectomy Versus Medical Treatments for Secondary Hyperparathyroidism in Patients Undergoing Dialysis: A Meta-analysis. Endocrine Practice. 2024. Epub 20240405. Doi: 10.1016/j.eprac.2024.04.002. Pubmed PMID: 38583772.
  11. Gimblet GR, Whitt J, Houson HA, Lin D, Guenter R, Rao TC, Wang D, Ness J, Gonzalez ML, Murphy MS, Gillis A, Chen H, Copland JA, Kenderian SS, Lloyd RV, Szkudlinski MW, Lapi SE, Jaskula-Sztul R. Thyroid-stimulating hormone receptor (TSHR) as a target for imaging differentiated thyroid cancer. Surgery. 2024 Jan;175(1):199-206. doi: 10.1016/j.surg.2023.05.045. Epub 2023 Oct 31. PMID: 37919223.
  12. Guenter R, Zheng-Pywell R, Herring B, Murphy M, Foote J, Benner K, Rose JB. Preclinical safety evaluation of continuous UV-A lighting in an operative setting. PLoS One. 2023 Nov 17;18(11):e0291083. doi: 10.1371/journal.pone.0291083. PMID: 37976243; PMCID: PMC10656011.
  13. Pukkanasut P, Whitt J, Guenter R, Lynch SE, Gallegos C, Rosendo-Pineda MJ, Gomora JC, Chen H, Lin D, Sorace A, Jaskula-Sztul R, Velu SE. Voltage-Gated Sodium Channel NaV1.7 Inhibitors with Potent Anticancer Activities in Medullary Thyroid Cancer Cells. Cancers. 2023; 15(10):2806. https://doi.org/10.3390/cancers15102806
  14. Gillis A, Zheng-Pywell R, McLeod C, Wang D, Ness JM, Guenter R, Whitt J, Prolla TA, Chen H, Gonzalez ML, Rose B, Lloyd RV, Jaskula-Sztul R, Lin D. Somatostatin Receptor Type 2 and Thyroid-Stimulating Hormone Receptor Expression in Oncocytic Thyroid Neoplasms: Implications for Prognosis and Treatment. Mod Pathol. 2023 Dec;36(12):100332. doi: 10.1016/j.modpat.2023.100332. Epub 2023 Sep 15. PMID: 37716507; PMCID: PMC10843045.
  15. Carter AM, Kumar N, Herring B, Tan C, Guenter R, Telange R, Howse W, Viol F, McCaw TR, Bickerton HH, Gupta P, Gillardon F, Woltering EA, Dhall D, Totenhagen J, Banerjee RR, Kurian EM, Reddy S, Chen H, Schrader J, Bart Rose J, Mukhtar MS, Bibb JA. Cdk5 drives formation of heterogeneous pancreatic neuroendocrine tumors. Oncogenesis. 2021 Dec 3;10(12):83. doi: 10.1038/s41389-021-00372-5. PMID: 34862365; PMCID: PMC8642406.
  16. Jiang Y, Guo Y, Hao J, Guenter R, Lathia J, Beck A, Hattaway R, Hurst D, Wang QJ, Liu Y, Cao Q, Krontiras H, Chen H, Silverstein R, Ren B. “Development of an arteriolar niche and self-renewal of breast cancer stem cells by lysophosphatidic acid/protein kinase D signaling.” Commun Biol 4, 780 (2021). https://doi.org/10.1038/s42003-021-02308-6
  17. Carmona Matos DM, Guenter R, Chen H. “Chapter 106: Data Presentation.” Translational Surgery: Handbook for Designing and Conducting Clinical and Translational Research. Elsevier Inc. (2022).
  18. Herring BR, Bonner A, Guenter RE, Vickers S, Yates C, Lee G, Dhall D, Chen H, Rose JB. Under-Representation of Racial Groups in Genomics Studies of Gastroenteropancreatic Neuroendocrine Neoplasms. Cancer Res Commun. 2022 Oct 12;2(10):1162-1173. doi: 10.1158/2767-9764.CRC-22-0093. PMID: 36969744; PMCID: PMC10035394.
  19. Budhwani KI, Patel ZH, Guenter RE, Charania AA. A hitchhiker’s guide to cancer models. Trends Biotechnol. 2022 May 7:S0167-7799(22)00101-9. doi: 10.1016/j.tibtech.2022.04.003. Epub ahead of print. PMID: 35534320.
  20. Guenter R, Eide J, Chen H, Rose JB, Jaskula-Sztul R. High-Throughput Analysis to Identify Activators of Notch Signaling. Methods Mol Biol. 2022;2472:49-56. doi: 10.1007/978-1-0716-2201-8_5. PMID: 35674891.
  21. Zheng-Pywell R, Fang A, AlKashash A, Awad S, Reddy S, Vickers S, Heslin M, Dudeja V, Chen H, Rose JB. Prognostic impact of tumor size on pancreatic neuroendocrine recurrence may have racial variance. Pancreas. Mar 1;50(3):347-352 PMCID: PMC8041062
  22. Zheng-Pywell R, Lopez-Aguiar A, Fields R, Vickers S, Yates C, Dudeja V, Chen H, Reddy S, Maithel SK, Rose JB. Are we undertreating Black patients with nonfunctional pancreatic neuroendocrine tumors? A critical analysis of current surveillance guidelines by race. J Am Coll Surg. 2022 Apr 1;234(4):599-606. PMID: 35380181; PMCID: PMC8988469
  23. McCaw TR, Inga E, Chen H, Jaskula-Sztul R, Dudeja V, Bibb JA, Ren B, Rose JB. Gamma Secretase Inhibitors in Cancer: A Current Perspective on Clinical Performance. Oncologist. 2021 Apr;26(4):e608-e621. doi: 10.1002/onco.13627. Epub 2021 Jan 2. PMID: 33284507; PMCID: PMC8018325.
  24. Galgano SJ, Wei B, Rose JB. PET Imaging of Neuroendocrine Tumors. Radiol Clin North Am. 2021 Sep;59(5):789-799. doi: 10.1016/j.rcl.2021.05.006. PMID: 34392919.
  25. Awad S, Alkashash AM, Amin M, Baker SJ, Rose JB. Biochemical Predictors of Response to Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma. Front Oncol. 2020 May 12;10:620. doi: 10.3389/fonc.2020.00620. PMID: 32477933; PMCID: PMC7235358.
  26. Ren B, Rose JB, Liu Y, Jaskula-Sztul R, Contreras C, Beck A, Chen H. Heterogeneity of Vascular Endothelial Cells, De Novo Arteriogenesis and Therapeutic Implications in Pancreatic Neuroendocrine Tumors. J Clin Med. 2019 Nov 14;8(11):1980. doi: 10.3390/jcm8111980. PMID: 31739580; PMCID: PMC6912347.
  27. Jiang Y, Guo Y, Hao J, Guenter R, Lathia J, Beck AW, Hattaway R, Hurst D, Wang QJ, Liu Y, Cao Q, Krontiras H, Chen H, Silverstein R, Ren B. Development of an arteriolar niche and self-renewal of breast cancer stem cells by lysophosphatidic acid/protein kinase D signaling. Commun Biol. 2021 Jun 24;4(1):780. doi: 10.1038/s42003-021-02308-6. PMID: 34168243; PMCID: PMC8225840.
  28. Asban A, Patel AJ, Reddy S, Wang T, Balentine CJ, Chen H. Cancer of the Endocrine System. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE eds. Abeloff’s Clinical Oncology. Philadelphia, PA: Elsevier 2020. pp 1074-1107.
  29. Carmona Matos DM, Chen H. Disorders of Water and Sodium Balance: Hyponatremia. In: Surgery. Toronto (ON): Decker Medicine; October 2019. DOI: 10.2310/7800.2410. Available at https://www.deckerip.com
  30. Fazendin JM, Kao L, Chen H. Joining and Becoming Involved in Surgical Societies. In: Wang TS, Beck AW, eds. Success in Academic Surgery: Building a Clinical Practice. Springer Nature Switzerland AG 2020. Pp107-112.
  31. Guenter R, Patel Z, Chen H. Notch Signaling in Thyroid Cancer. In: Reichrath J, Reichrath S, eds. Adv Exp Med Biol, Vol. 1287, Notch Signaling in Embryology and Cancer. Springer Nature Switzerland AG 2021.
  32. Atkinson R, Chen H, Cooper Z. Research Track and Focus. In: Telem D, Martin C, eds. Success in Academic Surgery: Diversity, Equity and Inclusion. Springer Nature Switzerland AG 2021.
  33. Liu X, Si Y, Kim S, Ou J, Lu Y, Ernst P, Chen K, Whitt J, Carter A, Markert J, Bibb J, Chen H, Jaskula-Sztul R, Zhou L.  Anti-SSTR2 Antibody-drug Conjugate for Neuroendocrine Tumor Therapy.  Cancer Gene Therapy 2020; DOI: 10.1038/s41417-020-0196-5 PMID: 32684623.
  34. Carter AM, Tan C, Pozo K, Telange R, Molinaro R, Guo A, De Rosa E, Martinez JO, Zhang S, Kumar N, Takahashi M, Wiederhold T, Ghayee HK, Oltmann SC, Pacak K, Woltering EA, Hatanpaa KJ, Nwariaku FE, Grubbs EG, Gill AJ, Robinson B, Gillardon F, Reddy S, Jaskula-Sztul R, Mobley JA, Mukhtar SM, Tasciotti E, Chen H, Bibb JA.  Phosphoprotein-based Biomarkers as Predictors for Cancer Therapy.  Proc Natl Acad Sci USA. (in press)
  35. Whitt J, Hong W, Telange R, Lin C, Bibb JA, Beebe D, Chen H, Jaskula-Sztul R. Non-Toxic Fragment of Botulinum Neurotoxin Type A and Monomethyl Auristatin E Conjugate for Targeted Therapy for Neuroendocrine Tumors.  Cancer Gene Therapy 2020; doi.org/10.1038/s41417-020-0167-x.
  36. Guenter R, Aweda T, Carmona Matos DM, Jang S, Whitt J, Cheng YQ, Liu XM, Chen H, Lapi S, Jaskula-Stzul R.  Overexpression of somatostatin receptor type 2 (SSTR2) in neuroendocrine tumors for improved [68Ga]DOTATATE imaging and treatment.  Surgery 2020; 167(1):189-196
  37. Herring B, Whitt J, Aweda T, Ou J, Guenter R, Lapi S, Berry J, Chen H, Liu X, Rose JB, Jaskula-Sztul R.  A Growth Model of Neuroendocrine Tumor Surrogates and the Efficacy of a Novel Somatostatin-Receptor Guided Antibody-Drug Conjugate: Perspectives on Clinical Response.  Surgery 2020; 167(1):197-203
  38. Wang R, Zheng-Pywell R, Chen HA, Bibb JA, Chen H, Rose JB.  Management of gastrointestinal neuroendocrine tumors. Clinical Medicine Insights: Endocrinology and Diabetes 2019. DOI:10.1177/1179551419884058.
  39. Ren B, Rose JB, Liu Y, Jaskula-Sztul R, Contreras C, Beck A, Chen H. Heterogeneity of vascular endothelial cells, de novo arteriogenesis and therapeutic implications in pancreatic neuroendocrine tumors.  J. Clin. Med. 2019, 8, 1980; doi:10.3390/jcm8111980).
  40. Si Y, Kim S, Zhang E, Tang Y, Jaskula-Sztul R, Markert JM, Chen H, Zhou L, Liu X.  Targeted Exosomes for Drug Delivery: Biomanufacturing, Surface Tagging, and Validation.  Biotechnology Journal 2019; 1900163
  41. Ernst P, Xu N, Song J, Qu J, Chen H, Goldberg MS, Darley-Usmar V, Zhang J, O’Rourke B, Liu X, Zhou L. Precisely control mitochondria with light to manipulate cell fate decision.  Biophysical Journal 2019 20;117(4):631-645
  42. Guenter RE, Aweda T, Carmona Matos DM, Whitt J, Chang AW, Cheng EY, Liu XM, Chen H, Lapi SE, Jaskula-Sztul R. Pulmonary carcinoid surface receptor modulation using histone deacetylase inhibitors. Cancers (Basel). 2019; 11(6): pii: E767.
  43. Carmona-Matos D, Jang S, Hijaz B, Aburjania Z, Cheng A, Lloyd RV, Chen H, Jaskula-Sztul R. Characterization of somatostatin receptors (SSTRs) expression and anti-proliferative effect of somatostatin analogues in aggressive thyroid cancers. Surgery. 2019; 165(1):64-68.

For a full list of publications, please visit the following links: